Rosa Rita Silva

1.5k total citations
18 papers, 253 citations indexed

About

Rosa Rita Silva is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Rosa Rita Silva has authored 18 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Rosa Rita Silva's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (4 papers) and Genetic factors in colorectal cancer (3 papers). Rosa Rita Silva is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (4 papers) and Genetic factors in colorectal cancer (3 papers). Rosa Rita Silva collaborates with scholars based in Italy and United Kingdom. Rosa Rita Silva's co-authors include Rossana Berardi, Stefano Cascinu, Mario Scartozzi, Chiara Pierantoni, Riccardo Giampieri, Gennaro Galizia, Alberto Zaniboni, Alessandra Mandolesi, Lucio Giustini and Renato Bisonni and has published in prestigious journals such as International Journal of Cancer, The Oncologist and Lung Cancer.

In The Last Decade

Rosa Rita Silva

16 papers receiving 243 citations

Peers

Rosa Rita Silva

ONCOL

PRM

PFM

W. Messersmith United States

Maria Grazia Rodriquenz Italy

E. Falcó Spain

Erica Quaquarini Italy

Thomas Göhler Germany

Valentina Polo Italy

Alberta Leon Italy

László Landherr Hungary

Sanjeev Deva New Zealand

Krisida Cerma Italy

W. Messersmith United States

Rosa Rita Silva

206 ×1.1

ONCOL

87 ×1.0

PRM

96 ×1.5

41 ×0.8

37 ×0.8

PFM

Citations per year, relative to Rosa Rita Silva Rosa Rita Silva (= 1×) peers W. Messersmith

Countries citing papers authored by Rosa Rita Silva

Since Specialization

Citations

This map shows the geographic impact of Rosa Rita Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Rita Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Rita Silva more than expected).

Fields of papers citing papers by Rosa Rita Silva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Rita Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Rita Silva. The network helps show where Rosa Rita Silva may publish in the future.

Co-authorship network of co-authors of Rosa Rita Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Rita Silva. A scholar is included among the top collaborators of Rosa Rita Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Rita Silva. Rosa Rita Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Fasola, Gianpiero, Giacomo Pelizzari, Francesco Grossi, et al.. (2023). Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals. The Oncologist. 28(6). e324–e330. 3 indexed citations

Giusti, Raffaele, Emanuela Scarpi, Katia Cannita, et al.. (2019). Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors. Supportive Care in Cancer. 28(3). 1051–1058.

Verna, Lucilla, et al.. (2017). Caring for Cancer Patients After the Italian Earthquakes: A Proposal From the Field. Disaster Medicine and Public Health Preparedness. 11(1). 4–6.

Puglisi, Fabio, Giancarlo Bisagni, Mariangela Ciccarese, et al.. (2016). A Delphi Consensus and Open Debate on the Role of First-Line Bevacizumab for HER2-Negative Metastatic Breast Cancer. Future Oncology. 12(22). 2589–2602. 5 indexed citations

Berardi, Rossana, et al.. (2015). Patient and Caregiver Needs in Oncology. An Italian Survey. Tumori Journal. 101(6). 621–625. 6 indexed citations

Berardi, Rossana, et al.. (2014). Compliance with breast and cervical cancer screening programs in women: results from a population-based study.. PubMed. 99(5). 565–71. 8 indexed citations

Berardi, Rossana, et al.. (2013). Compliance with Breast and Cervical Cancer Screening Programs in Women: Results from a Population-Based Study. Tumori Journal. 99(5). 565–571. 7 indexed citations

Scartozzi, Mario, Cristian Loretelli, Rossana Berardi, et al.. (2011). Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients. Digestive and Liver Disease. 44(1). 74–79. 3 indexed citations

Scartozzi, Mario, Alessandra Mandolesi, Riccardo Giampieri, et al.. (2011). The Role of HER-3 Expression in the Prediction of Clinical Outcome for Advanced Colorectal Cancer Patients Receiving Irinotecan and Cetuximab. The Oncologist. 16(1). 53–60. 53 indexed citations

10.

Cascinu, Stefano, Gennaro Galizia, Roberto Labianca, et al.. (2010). Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial. Cancer Chemotherapy and Pharmacology. 68(1). 37–43. 15 indexed citations

11.

Scartozzi, Mario, Alessandra Mandolesi, Riccardo Giampieri, et al.. (2010). Insulin‐like growth factor 1 expression correlates with clinical outcome in K‐RAS wild type colorectal cancer patients treated with cetuximab and irinotecan. International Journal of Cancer. 127(8). 1941–1947. 64 indexed citations

12.

Cascinu, Stefano, Mario Scartozzi, Chiara Pierantoni, et al.. (2007). COX-2 and NF-KB Overexpression Is Common in Pancreatic Cancer but Does Not Predict for COX-2 Inhibitors Activity in Combination With Gemcitabine and Oxaliplatin. American Journal of Clinical Oncology. 30(5). 526–530. 29 indexed citations

13.

Scartozzi, Mario, Vittorio Franciosi, Nicoletta Campanini, et al.. (2006). Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients. Lung Cancer. 53(1). 103–109. 27 indexed citations

14.

Berardi, Rossana, et al.. (2005). Elderly Patients with Advanced Colorectal Cancer: Tolerability and Activity of Chemotherapy. Tumori Journal. 91(6). 463–466. 12 indexed citations

15.

Cascinu, Stefano, Vincenzo Catalano, Andrea Piga, et al.. (2003). The Role of Levamisole in the Adjuvant Treatment of Stage III Colon Cancer Patients: A Randomized Trial of 5-Fluorouracil and Levamisole Versus 5-Fluorouracil Alone. Cancer Investigation. 21(5). 701–707. 10 indexed citations

16.

Silva, Rosa Rita, et al.. (1996). A Phase II Study of Mitomycin C, Vindesine and Cisplatin Combined with Alpha Interferon in Advanced Non-Small Cell Lung Cancer. Tumori Journal. 82(1). 68–71. 5 indexed citations

17.

Mattioli, Rodolfo, et al.. (1993). Mitomycin C, 5Fluorouracil and Folinic Acid in Combination with Alpha 2b Interferon for Advanced Colorectal Cancer. Tumori Journal. 79(6). 393–396. 1 indexed citations

18.

Menichetti, Ettore Tito, et al.. (1989). Etoposide and Mitomycin-C in Pretreated Metastatic Breast Cancer. Tumori Journal. 75(5). 473–474. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact